Literature DB >> 19043254

Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis.

Hyoung-Chul Oh1, Jae Gyu Kim, Jeong Wook Kim, Kwang Sun Lee, Mi Kyung Kim, Kyong Choun Chi, Yong Seok Kim, Ki Hyun Kim.   

Abstract

A 59-year-old man presented with recent onset jaundice. Initial laboratory and radiologic findings suggested autoimmune pancreatitis (AIP) with consequent obstructive jaundice. All serologic markers for AIP were, however, normal. To confirm the histologic finding of AIP and exclude the possibility of cancer at the thickened segment of common bile duct, cholangioscopic examination was performed and bile duct cancer was observed. The resected specimen showed typical features of AIP throughout the entire pancreas and early carcinomatous change on a background of abundant IgG4-positive cells in the common bile duct. Although chronic biliary inflammation and cholestasis are among bile duct cancer risk factors, the cause-and-effect relationship between sclerosing cholangitis and bile duct cancer needs to be determined by further study, as between AIP and pancreatic cancer. Importantly, histologic exclusion of malignancy is another essential step in the diagnosis of AIP and sclerosing cholangitis as malignancy may coexist in bile duct as well as in the pancreas.

Entities:  

Mesh:

Year:  2008        PMID: 19043254     DOI: 10.2169/internalmedicine.47.1347

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  15 in total

1.  Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis.

Authors:  Takashi Tomiyama; Kazushige Uchida; Mitsunobu Matsushita; Tsukasa Ikeura; Toshiro Fukui; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-12-25       Impact factor: 7.527

Review 2.  Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.

Authors:  Hiep Nguyen Canh; Kenichi Harada
Journal:  Med Mol Morphol       Date:  2016-06-27       Impact factor: 2.309

3.  IgG4-associated cholangitis with cholangiocarcinoma.

Authors:  Beate K Straub; Irene Esposito; Daniel Gotthardt; Boris Radeleff; Dalibor Antolovic; Christa Flechtenmacher; Peter Schirmacher
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

4.  Immunoglobulin G4-mediated sclerosing cholangitis as a risk factor for cholangiocarcinoma: A case report.

Authors:  Karin E Koopman; Elisabeth Bloemena; Geert Kazemier; Michael Klemt-Kropp
Journal:  Mol Clin Oncol       Date:  2016-09-30

5.  The rare case report of interstitial lung disease with normal serum level of IgG4 developed six years after treatment of autoimmune pancreatitis.

Authors:  Tatjana Adzic-Vukicevic; Jelena Stojsic; Aleksandra Barac; Ana Blanka Protic; Sladjana Andrejevic; Snezana Raljevic
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

6.  Cholangiocarcinoma developed in a patient with IgG4-related disease.

Authors:  Akitoshi Douhara; Akira Mitoro; Emi Otani; Masanori Furukawa; Kosuke Kaji; Masakazu Uejima; Masayoshi Sawai; Motoyuki Yoshida; Hitoshi Yoshiji; Junichi Yamao; Hiroshi Fukui
Journal:  World J Gastrointest Oncol       Date:  2013-08-15

7.  Differential diagnosis of pancreatobiliary carcinoma from autoimmune pancreatitis-related diseases: a report of three cases.

Authors:  Michihiro Hayashi; Yoshifumi Arisaka; Atsushi Takeshita; Yusuke Tominaga; Takayuki Ki; Daisuke Masuda; Fumitoshi Hirokawa; Yutaro Egashira; Motomu Tsuji; Kazuhiro Yamamoto; Kazuhide Higuchi; Nobuhiko Tanigawa
Journal:  J Gastrointest Cancer       Date:  2011-12

Review 8.  Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Norio Kubo; Hideki Suzuki; Tsutomu Kobayashi; Kenichiro Araki; Shigeru Sasaki; Wataru Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2012 Apr-Jun

9.  Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.

Authors:  Yasufumi Masaki; Nozomu Kurose; Motohisa Yamamoto; Hiroki Takahashi; Takako Saeki; Atsushi Azumi; Shinji Nakada; Shoko Matsui; Tomoki Origuchi; Susumu Nishiyama; Kazunori Yamada; Mitsuhiro Kawano; Akira Hirabayashi; Keita Fujikawa; Tomoko Sugiura; Masanobu Horikoshi; Naoto Umeda; Hiroshi Minato; Takuji Nakamura; Haruka Iwao; Akio Nakajima; Miyuki Miki; Tomoyuki Sakai; Toshioki Sawaki; Takafumi Kawanami; Yoshimasa Fujita; Masao Tanaka; Toshihiro Fukushima; Katumi Eguchi; Susumu Sugai; Hisanori Umehara
Journal:  Int J Rheumatol       Date:  2012-05-10

10.  Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma.

Authors:  Taku Tabata; Terumi Kamisawa; Seiichi Hara; Sawako Kuruma; Kazuro Chiba; Go Kuwata; Takashi Fujiwara; Hideto Egashira; Koichi Koizumi; Junko Fujiwara; Takeo Arakawa; Kumiko Momma; Masanao Kurata; Goro Honda; Koji Tsuruta; Takao Itoi
Journal:  Gut Liver       Date:  2013-02-07       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.